Pharmaceutical Industry

Pharmaceuticals Healthcare Policy Drug Pricing Healthcare Policy Health Policy Drug Pricing Economics Drug Manufacturing Drug Manufacturers Access to Medicines Market Dynamics

Moderna Withdraws Flu-COVID Vaccine Application After FDA Requests More Data

The company plans to resubmit its application later this year following interim results from its Phase 3 flu vaccine trial, expected this summer.

Trump Orders U.S. Drug Prices Tied to Lowest OECD Rates, Sparking Concerns Over Global Impact

Trump's Executive Order Enacts Global Benchmark for U.S. Drug Prices

Trump Expands Drug Pricing Model to Medicare and Medicaid, Targets Global Parity

Rep. Ro Khanna Files Legislation to Codify Trump’s Drug Pricing Executive Order

EU Court Overturns Commission's Refusal to Release von der Leyen-Pfizer Texts

Trump’s Executive Order Targets Prescription Drug Prices and PBMs

Trump's Executive Order Targets U.S. Drug Price Disparities

Trump’s Executive Order Targets U.S. Drug Prices with Foreign Rate Parity

Nationwide Recall of Eye Care Products Over Sterility Concerns

Trump Signs Sweeping Order to Cap U.S. Drug Prices at Global Lows

Trump to Revive Medicare Drug Pricing Plan via Executive Order

Wall Street Journal Denounces Trump's Medicaid Drug Pricing Plan

Rep. Shri Thanedar Faces Scrutiny Over Animal Abandonment While Pursuing Trump Impeachment

Novo Nordisk Partners with Telehealth Firms to Expand Wegovy Access

Australia Subsidizes Esketamine Spray for Treatment-Resistant Depression

Trump Administration’s Planned 25% Tariffs on Pharmaceuticals Expected to Raise U.S. Drug Costs by $51 Billion Annually

Federal Judge Upholds FDA Ban on Compounded Ozempic and Wegovy Copies

Eli Lilly Expands Legal Fight Against Compounded GLP-1 Drugs

Pharma CEOs Urge EU to Reform Pricing Policies as U.S. Investments Surge